Transfar Capital key facts
- Transfar Capital is a other based in Hangzhou, Zhejiang with 4 tracked portfolio companies.
- Notable positions include Meimiao New Materials, Biyo Pharma, LingyiMed.
About Transfar Capital
Transfar Capital is a corporation based in Hangzhou, China. Established in 1995, the firm operates across multiple sectors, including business services, scientific research and technical services, and finance. The assets are managed by the executive management team.
Transfar Capital portfolio at a glance
4 portfolio companies are on record for Transfar Capital, including Meimiao New Materials, Biyo Pharma and LingyiMed.
Is this your firm? Sign in with your work email to keep it current, or tell us what's wrong.
Free account
See more of the book
- ·The top 10 names in the book — of 4 recorded positions
- ·Watchlist + alerts for Transfar Capital's activity
Portfolio
4 companies · priced for members| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Meimiao New Materials | — | ▮ | ▮ | ▮ |
| Biyo Pharma | — | ▮ | ▮ | ▮ |
| LingyiMed | — | ▮ | ▮ | ▮ |
+ 1 more companies · all 4, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | ||||
Frequently asked about Transfar Capital
- What companies does Transfar Capital invest in?
- Transfar Capital has 4 recorded portfolio companies, including Meimiao New Materials, Biyo Pharma, LingyiMed.